Corporate Law
500 A.2d 1346 (Del. 1985)
Study notes for Moran v. Household International, Inc.: professor notes, cold call prep, exam angles, and memory aids.
The board of directors has the authority to adopt defensive measures like poison pills to protect the company from hostile takeovers under Delaware law.
In Moran v. Household International, Inc., the Delaware Supreme Court explored the balance of power between a corporation's board of directors and its shareholders in the context of hostile takeovers. The court affirmed that the adoption of the 'poison pill' strategy was a valid exercise of the board's authority to protect the company and its shareholders. Professors may emphasize the court's reasoning regarding the fiduciary duties of the board and the need for directors to consider the long-term interests of the corporation, extending beyond immediate shareholder profit. This case is pivotal for understanding how Delaware corporate law permits defensive measures against potential threats to corporate control.
Additionally, the emphasis may be placed on the implications of this decision for corporate governance, particularly in how it empowers boards to take preemptive action against hostile bids. This ruling has laid a foundational precedent for the discourse on the limits and extent of shareholder rights versus the authority vested in corporate directors. It serves as a key case in corporate law discussions around defensive tactics and shareholder activism.
Moran's Poison Pill Protects.
| Case | Distinction |
|---|---|
| Unocal Corp. v. Mesa Petroleum Co. | Unocal involved enhanced scrutiny standards for defensive measures, while Moran highlighted the board's general authority to adopt such measures without specific legal standards. |
| Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc. | Revlon emphasized the obligation of the board to maximize shareholder value during a sale, contrasting with Moran where protection against takeovers was deemed valid regardless of immediate shareholder profit. |
Supporters argue that allowing boards to adopt poison pills promotes long-term stability and protects against unfair acquisition tactics that could harm shareholders.
Critics argue that such measures entrench management and limit shareholder influence, potentially leading to misalignment of management interests with those of shareholders.
This case frequently appears on exams focused on corporate governance and the powers of corporate boards in defending against hostile takeovers, emphasizing the legal reasoning behind defensive strategies.